Joseph McGuirk, DO

Medical Director, Blood and Marrow Transplant
Professor of Medicine, The University of Kansas Medical Center


Joseph McGuirk, DO, has been a principal investigator in more than 40 clinical trials and has authored or co-authored more than 80 papers, abstracts, presentations and posters. He has presented at more than a dozen universities and associations, including Dana-Farber Cancer Center and Beth Israel Hospital in Boston, the Chinese Academy of Medical Sciences and Peking Union Medical College in Beijing, the American Society of Hematology Annual Meeting and the Kansas Association of Osteopathic Medicine. He is also a member of numerous cancer center committees, including blood utilization, multidisciplinary cancer, graft sources, infection prevention and hematology/BMT disease working groups.

Dr. McGuirk completed his residency at Yale and his fellowship training at Memorial Sloan-Kettering Cancer Center in New York City. He served as medical director of Kansas City Cancer Center’s blood and marrow transplant program at St. Luke’s Hospital before joining The University of Kansas Cancer Center in 2007.

In 2010, Dr. McGuirk was named honorary editorial board member of Blood and Lymphatic Cancer: Targets and Therapy, an international, peer-reviewed journal focusing on blood and lymphatic cancer research, identification of therapeutic targets, and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient. He has been named one of Kansas City Magazine’s Super Doctors every year from 2006 to 2009, and a Top Doctor in 2008 by Ingram’s Magazine.

Clinical Trials

Medical research finds ways to help people live longer, improve their quality of life and manage or cure disease. This is possible because of the people who volunteer to participate in clinical trials.

Learn more about clinical trials »
View clinical trials »